Quidelortho Corpoation ($QDEL) Stock Forecast: Up 5.1% Today

What is Quidelortho Corpoation?

QuidelOrtho (QDEL) is a diagnostic healthcare company that has experienced a strong bullish movement in the stock market today.

Why is Quidelortho Corpoation going up?

QDEL stock is up 5.1% on Dec 11, 2025 15:06

• QuidelOrtho's recent 39.1% price surge has sparked discussions about its valuation, with analysts suggesting the stock is undervalued based on various metrics.
• The insider buying activity by the company's CEO and a director has reignited investor interest, indicating confidence in the company's future prospects.
• Despite concerns about declining COVID testing demand and integration challenges, QuidelOrtho's potential return to profitability this year and its current discount to analyst targets have contributed to the bullish market movement.
• The combination of positive insider buying, potential operational improvements, and undervaluation compared to analyst targets may have been key drivers behind QuidelOrtho's strong bullish performance today.

QDEL Price Chart

QDEL Technical Analysis

QDEL News

Is QuidelOrtho A Bargain After Recent 39.1% Price Surge?

QuidelOrtho has seen a significant price surge recently but remains down year-to-date, prompting questions about its valuation. Despite the volatile share price history, Simply Wall St's analysis suggests the stock is undervalued, scoring a 5/6 on their valuation checks. Both Discounted Cash Flow and Price to Sales analyses indicate QuidelOrtho is trading below its intrinsic value and fair ratio, respectively.

https://simplywall.st/stocks/us/healthcare/nasdaq-qdel/quidelortho/news/is-quidelortho-a-bargain-after-recent-391-price-surge

Ann Rhoads, director at QuidelOrtho, buys $21k in stock By Investing.com

Ann Rhoads, a director at QuidelOrtho (NASDAQ:QDEL), recently purchased 750 shares of common stock for $21,206, bringing her direct ownership to 15,021 shares. This comes as the diagnostic healthcare company, currently valued at $1.95 billion, shows a 48% recovery from its 52-week low despite a significant debt burden. Analysts anticipate QuidelOrtho will return to profitability this year, with a 15% upside potential based on their consensus price target.

https://in.investing.com/news/insider-trading-news/ann-rhoads-director-at-quidelortho-buys-21k-in-stock-93CH-5147836

QuidelOrtho (QDEL): Revisiting the Valuation After Insider Buying and a Recent Shift in Investor Sentiment

QuidelOrtho (QDEL) is garnering renewed investor interest following recent insider buying by its CEO and a director. Despite a recent share price uptick, long-term momentum is still recovering, and the stock trades at a significant discount to analyst targets. The article explores whether QuidelOrtho is undervalued, citing a narrative fair value of $37.67 based on anticipated operational improvements and margin resets, while also cautioning about risks from declining COVID testing demand and integration challenges.

https://simplywall.st/stocks/us/healthcare/nasdaq-qdel/quidelortho/news/quidelortho-qdel-revisiting-the-valuation-after-insider-buyi

Trending Today

Beyond Meat Inc. ($BYND) Stock Forecast: Up 5.7% Today

Comcast Corporation Class A Common Stock ($CMCSA) Stock Forecast: Up 5.0% Today

National Oilwell Varco Inc. ($NOV) Stock Forecast: Down 5.1% Today

Phillips 66 ($PSX) Stock Forecast: Down 5.1% Today

Pfizer Inc. ($PFE) Stock Forecast: Down 5.1% Today

Humana Inc. ($HUM) Stock Forecast: Down 5.1% Today

Cytokinetics, Incorporated ($CYTK) Stock Forecast: Down 5.0% Today

S&P 500 Index ($SPX) Index Forecast: Down 0.8% Today

Apache Corporation ($APA) Stock Forecast: Down 5.1% Today

Wix.com Ltd. ($WIX) Stock Forecast: Up 5.1% Today

Quidelortho Corpoation Price History

08.04.2025 - QDEL Stock was up 38.6%

• QDEL stock experienced a bullish movement today.
• The strong bullish movement can be attributed to QDEL's Q1 earnings beat and the expansion of margins.
• Despite soft overall top-line results, the solid performances by the Labs and Immunohematology units, as well as growth in the EMEA and Other regions, contributed to the positive market sentiment.
• Investors seem optimistic about QDEL's future prospects following the earnings and revenue surprises in the first quarter of 2025.

08.04.2025 - QDEL Stock was up 28.5%

• QDEL showed strong bullish movement today due to the company's impressive Q1 earnings and revenue results, surpassing analyst estimates.
• The 27.59% earnings surprise and 0.30% revenue beat have boosted investor confidence in the company's growth prospects.
• Positive financial performance indicates high demand for QDEL's diagnostic healthcare solutions, positioning the stock well in the market.

28.09.2025 - QDEL Stock was down 5.8%

• The release of Episode 52 of the Science Bytes podcast featuring a Senior Global Product Manager might not have resonated well with investors, possibly indicating a lack of significant positive developments or catalysts for the company.
• Investors may have been expecting more substantial news or updates from QuidelOrtho Corporation, leading to disappointment and a bearish sentiment in the market.
• The market might be reacting to a perceived lack of innovation or growth potential in the company's recent initiatives, causing a negative impact on QDEL's stock price.

04.05.2025 - QDEL Stock was up 7.2%

• QDEL displayed a significant bullish movement, possibly influenced by favorable news or financial outcomes.
• The general bullish sentiment in the market likely played a role in driving QDEL's stock price higher.
• Despite challenges faced by other companies such as CrowdStrike during pre-market trading, QDEL's outstanding performance captured investors' attention and resulted in a surge in its stock price.
• Investors' favorable response to QDEL's strategic moves, product advancements, or market positioning could have contributed to the positive trend in the stock.

29.06.2025 - QDEL Stock was down 5.9%

• The urgent need for early detection in drug overdose cases may have raised concerns about the potential impact on Quidel's diagnostic testing products.
• The evolving challenges facing emergency departments could indicate a higher demand for Quidel's products, but the bearish movement might suggest that investors are uncertain about the company's ability to meet this demand effectively.
• The limits of Narcan could be seen as a potential limitation for Quidel's products if they are unable to provide comprehensive solutions for drug overdose detection.

21.04.2025 - QDEL Stock was down 5.1%

• Despite QDEL's strong product portfolio and growth prospects, the stock experienced a bearish movement today.
• Investors might have reacted to broader market trends or specific industry news, causing a sell-off in QDEL shares.
• It's possible that profit-taking or concerns about future performance overshadowed the positive aspects.
• Traders might be reevaluating their positions in QDEL amidst market uncertainties, leading to the bearish movement despite the company's growth potential.

07.07.2025 - QDEL Stock was down 9.8%

• Despite a recent positive earnings report and margin expansion, QDEL experienced a strong bearish movement today.
• Soft revenue and ongoing business headwinds may have outweighed the positive earnings beat, resulting in the bearish market movement.
• Concerns about the sustainability of margin improvements in a challenging business environment likely triggered a sell-off of QDEL shares by investors.

10.11.2025 - QDEL Stock was up 5.0%

• The recent insider purchases by QDEL's CEO and a director have likely fueled the uptrend, indicating a belief in the company's future prospects.
• Although JPMorgan Chase & Co. reduced its stake in QDEL, the company exceeded quarterly earnings and revenue predictions, delivering a promising outlook for FY2025.
• The varied analyst consensus on QDEL, with a rating of "Reduce," may have introduced some market uncertainty. However, a projected fair value of $37.67, considering operational enhancements and margin adjustments, could have comforted investors.
• QDEL's stock currently trades at a notable discount to analyst targets, combined with a positive company outlook, contributing to today's bullish market performance.

06.05.2025 - QDEL Stock was down 5.1%

• QDEL stock has been on a downward trend since the last earnings report, with a decline of 18%. This negative performance could be contributing to today's bearish movement.
• The overall market sentiment seems mixed, with U.S. stock futures slightly higher and the Dow gaining around 0.1%. However, specific companies like CrowdStrike Holdings, Inc. are experiencing sharp falls after reporting their first-quarter results. This negative sentiment in the tech sector could be impacting QDEL's stock price as well.
• Investors might be cautious about QDEL's future performance, especially considering the uncertainty surrounding earnings estimates. This uncertainty could be adding to the bearish pressure on the stock.

06.10.2025 - QDEL Stock was down 21.9%

• The bearish movement in QDEL stock today could be attributed to:
• 1. Despite beating earnings and revenue estimates in Q3, the decline in respiratory revenue might have raised concerns among investors about the company's future growth prospects.
• 2. The market may have reacted negatively to the bearish overall sentiment in the healthcare sector, overshadowing the positive aspects of QDEL's strong performance.
• 3. Investors might be focusing more on the potential impact of the declining respiratory revenue rather than the overall positive earnings report, leading to a sell-off in QDEL stock.

11.11.2025 - QDEL Stock was up 5.1%

• QuidelOrtho's recent 39.1% price surge has sparked discussions about its valuation, with analysts suggesting the stock is undervalued based on various metrics.
• The insider buying activity by the company's CEO and a director has reignited investor interest, indicating confidence in the company's future prospects.
• Despite concerns about declining COVID testing demand and integration challenges, QuidelOrtho's potential return to profitability this year and its current discount to analyst targets have contributed to the bullish market movement.
• The combination of positive insider buying, potential operational improvements, and undervaluation compared to analyst targets may have been key drivers behind QuidelOrtho's strong bullish performance today.

01.09.2025 - QDEL Stock was up 5.3%

• Quidel Corporation (QDEL) experienced a strong bullish movement recently.
• The launch of the FDA-approved QUICKVUE Influenza + SARS Test for professional use by QDEL has expanded its portfolio, attracting investors' attention.
• The addition of this new test to QDEL's respiratory testing lineup is seen as a strategic move to capitalize on the ongoing demand for comprehensive diagnostic solutions, potentially driving up the stock price.
• The market's positive reaction to this development indicates confidence in QDEL's ability to continue innovating and meeting market needs effectively.